OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily
OBAGI-C RX SYSTEM
Approved
Approval ID
18803dfb-5b9c-48cd-a838-519c8bac3361
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 2, 2020
Manufacturers
FDA
Obagi Cosmeceuticals LLC
DUNS: 790553353
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
HYDROQUINONE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code62032-122
Product Classification
G
Generic Name
HYDROQUINONE
Product Specifications
Route of AdministrationTOPICAL
Effective DateJune 2, 2020
FDA Product Classification
INGREDIENTS (8)
HYDROQUINONEActive
Quantity: 40 mg in 1 mL
Code: XV74C1N1AE
Classification: ACTIB
ASCORBIC ACIDInactive
Code: PQ6CK8PD0R
Classification: IACT
DIPROPYLENE GLYCOLInactive
Code: E107L85C40
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
PROPYLENE CARBONATEInactive
Code: 8D08K3S51E
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT